Loading...
OTCM
RONN
Market cap0kUSD
Dec 04, Last price  
0.00USD
1D
0.00%
1Q
0.00%
Name

Lee Pharmaceuticals

Chart & Performance

D1W1MN
OTCM:RONN chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
195.34%
Rev. gr., 5y
%
Revenues
0k
-100.00%
55,800,00030,900,00032,900,00029,000,00019,500,00013,400,00013,700,00013,800,00010,900,0009,139,0006,937,0008,815,0008,252,0008,400,0008,801,0008,469,0009,226,0008,758,0008,533,0000
Net income
-3m
L+177.79%
5,900,000-1,900,000-900,000-600,000-1,000,000-3,900,000-200,000-400,000-700,000-1,282,000-970,00029,000-988,000-600,00016,00047,000-911,000-1,104,000-1,229,000-3,414,000
CFO
-264k
L-70.55%
100,000-600,0001,500,000-300,000744,000418,0001,026,000524,0001,700,000447,0001,490,000-121,00062,000-897,000-264,185

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Lee Pharmaceuticals, Inc. manufactures personal care and cosmetic products. The company specializes in personal care products, such as lip balm for chapped lips, nasal spray, nail care products, depilatories, and quit smoking items. Its products category includes aloe vera products, antacids, baby care, cosmetics and douche, cough and cold products, depilatories and waxes, laxatives, lip balm products, men's personal care, oral care, pain relievers, personal care, skin care, tobacco accessories, topical ointments/creams, and vitamins and nutritional items. The company also provides private label and contract manufacturing services. It offers its products through retailers and wholesalers, as well as online. The company was incorporated in 1971 and is based in South El Monte, California.
URL
https://www.leepharmaceuticals.com
IPO date
Mar 26, 1971
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FY
2024‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT